Description
Bookmark
Precision Proteomics Inc. (PPI) is a biotechnology firm that develops and commercializes a unique proteomics platform for fundamental, preclinical, and clinical research, as well as next-generation precision medicine research.
PPI's unique technology, which includes the SH2 Supberbinder (SH2S), enables cutting-edge proteomics to meet the demands of our customers and colleagues in therapeutics research, development, and clinical use. The technology developed by PPI can systematically and statistically profile activations of critical signal pathways and regulatory networks that drive pathogenesis and the development of therapeutic resistance.
